Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #40499 on Applied DNA Sciences Inc (APDN)
mcsharkey
05/16/16 4:39 PM
#40502 RE: mrbigglessworth #40499
TRENTON, N.J. (AP) — Pfizer is fortifying its key immunology and inflammation drug business, snapping up a small maker of skin disorder treatments for about $5.2 billion, weeks after the U.S. Treasury Department torpedoed Pfizer's planned $160 billion deal for Allergan PLC.